ArticleJournal of conservative dentistry and endodontics2026
Assessment of postoperative pain after the use of calcium silicate bioceramic sealer - BioRoot RCS: A double-blinded randomized clinical trial.
Article in Journal of conservative dentistry and endodontics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: This randomized clinical trial aimed to assess the postoperative pain after root canal treatment performed in a single visit with BioRoot root canal sealer (BRCS) or AH Plus root canal sealer (ARCS) in patients with different pulpal and periapical diagnosis. Materials and Methods: The double-blind, single-center, trial procedure began after ethical clearance and registration with the Indian clinical trial registry (CTRI/2021/09/036338), and it follows the Preferred Reporting Items for RAndomized Trials in Endodontic 2020 criteria. The trial included 94 patients with a Periapical Index <3 and preoperative pain score calculated with visual analogue scale (VAS) ≤4 and were randomly assigned to two sealer groups: BRCS and ARCS. Postoperative pain was evaluated at 2, 4, 6, 8, 24, and 48 h. Independent and paired sample Results: The trial included 86 patients after dropouts and exclusions. The BRCS group had statistically significant lower pain compared to ARCS at 4 (P = 0.04), 6 (P = 0.05), and 8 h (P = 0.03) intervals. Comparing pain reduction between the groups, there is an increase in pain level in the ARCS group for the initial 4-h time period, but they were not statistically significant. When the diagnostic parameter was compared, ARCS exhibited significantly higher pain in the symptomatic irreversible pulpitis with symptomatic apical periodontitis for the initial 6 h (P = 0.01). Conclusion: BRCS, when used for single visit endodontic treatment, decreased the occurrence of postoperative pain at 4, 6, and 8 h when compared to the ARCS group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.